CD8-Targeted, Integrating Viral Vectors Transduce Resting T Cells and Enable Extracorporeal Delivery (ECD) for Rapid CAR T Cell TherapiesJesse Green, Terry J. Fry, Kutlu G. Elpek et al.|Blood|2022Cited by 5
Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell TherapyVandana Chaturvedi, Terry J. Fry, Jesse Green et al.|Blood|2023Cited by 3
Abstract LB311: Increased potency of CD8-targeted fusosomes enhances CAR gene delivery to resting primary T cellsJesse Green, Terry J. Fry, Brian Granger et al.|Cancer Research|2023Cited by 0
Abstract 2734: Modulation of resting T cell status to enhance transduction and CAR T expansion following exposure to CD8-targeted fusosomesBrian Dolinski, Terry J. Fry, Vandana Chaturvedi et al.|Cancer Research|2023Cited by 0
Abstract 2735: Development of a novel, fully human anti-CD19 chimeric antigen receptor for <i>in vivo</i> delivery via CD8-targeted fusosomeJeremy M. Kinder, Aaron E. Foster, Christie Ciarlo et al.|Cancer Research|2023Cited by 0